Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 22, 2026 08:00 ET | Source: CareCloud, Inc

CareCloud’s Wellsoft Ranked #1 EHR by Black Book 2026 for Emergency Medicine

SOMERSET, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and AI-powered solutions, today announced...
January 20, 2026 08:30 ET | Source: Machina Medical Corp

Machina Medical Receives FDA 510(k) Clearance for MFUSE External Bleeding Control Device

Machina Medical received FDA 510(k) clearance for MFUSE, a single-use device providing rapid, temporary external control of moderate to severe bleeding.
January 14, 2026 08:00 ET | Source: ApolloMD Inc.

ApolloMD Announces Leadership Appointments to Strengthen Hospital Operations and Revenue Performance

ApolloMD announced leadership appointments strengthening hospital operations, revenue cycle performance, and long-term partnership stability.
November 06, 2025 04:03 ET | Source: Research and Markets

United States Emergency Medicine KOLs Fair-Market Value Compensation Rates Report 2025: An Independent Reference for Negotiations with Thought Leaders (KOLs) and Healthcare Providers (HCPs)

Dublin, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The "United States Fair-Market Value Compensation Rates for Emergency Medicine KOLs" report has been added to ResearchAndMarkets.com's offering.This report...
May 23, 2025 08:00 ET | Source: ScribeCanada

ScribeCanada to Showcase Care Team Support Solutions at Two Leading Healthcare Conferences this Spring

VANCOUVER, B.C., May 23, 2025 (GLOBE NEWSWIRE) -- ScribeCanada, a care team support solutions provider, is excited to announce its participation in two leading healthcare conferences this spring. ...
March 29, 2025 12:32 ET | Source: SERB Pharmaceuticals

SFJ Pharmaceuticals & SERB Pharmaceuticals Present Positive Final Results from Pivotal Ph 3 REVERSE-IT Trial of Bentracimab for the Reversal of Antiplatelet Effects of Ticagrelor in Patients Requiring Surgery or Experiencing Major Bleeding

PLEASANTON, CA, March 29, 2025 (GLOBE NEWSWIRE) -- SFJ Pharmaceuticals (SFJ) and SERB Pharmaceuticals (SERB) announced today the final results of the pivotal Phase 3 REVERSE-IT trial designed to...
January 23, 2025 11:15 ET | Source: BioBridge Global

South Texas Blood & Tissue First US Civilian Blood Center to Install Velico’s FrontlineODP™ Spray Dried Plasma System

San Antonio, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Velico Inc. launched a groundbreaking collaboration with South Texas Blood & Tissue (STB&T), a subsidiary of San Antonio-based nonprofit...
January 23, 2025 07:00 ET | Source: Global Market Insights Inc.

Acute Care Telemedicine Market to hit USD 106.5 billion by 2034, says Global Market Insights Inc.

Selbyville, Delaware, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Acute care telemedicine market size was valued at USD 26.7 billion in 2024 and is projected to grow at a CAGR of 14.9% from 2025 to 2034....
October 21, 2024 08:00 ET | Source: SERB Pharmaceuticals

SERB Pharmaceuticals expands leading emergency care portfolio with acquisition of Aurlumyn™ (iloprost IV) for severe frostbite

Philadelphia, PA, Oct. 21, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today the acquisition of Aurlumyn™ (iloprost IV), the only FDA approved...
August 02, 2024 08:35 ET | Source: SERB Pharmaceuticals

FDA has accepted a BLA for bentracimab, the first and only ticagrelor reversal agent, for filing and priority review

Pleasanton, CA and Philadelphia, PA, Aug. 02, 2024 (GLOBE NEWSWIRE) -- SFJ Pharmaceuticals, (SFJ), Sponsor of the bentracimab Biologics License Application (BLA), and SERB Pharmaceuticals (SERB),...